The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 174-183

  Frisullo, Giovanni ^a   Mirabella, Massimiliano ^a   Angelucci, Francesco ^b   Caggiula, Marcella ^b   Morosetti, Roberta ^a   Sancricca, Cristina ^a   Patanella, Agata Katia ^a   Nociti, Viviana ^a,b   Iorio, Raffaele ^a   Bianco, Assunta ^a   Tomassini, Valentina ^c   Pozzilli, Carlo ^c   Tonali, Pietro Attilio ^a,b   Matarese, Giuseppe ^d   Batocchi, Anna Paola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR   (Italy)

Author keywords

Leptin; Multiple sclerosis; SOCS3; STAT3; Transcription factors

Indexed keywords

INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; BODY MASS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REMISSION;

ADULT; BACTERIAL TOXINS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; HUMANS; LEPTIN; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RADIOIMMUNOASSAY; RECEPTORS, LEPTIN; SEX FACTORS; STAT3 TRANSCRIPTION FACTOR;

EID: 36749018195     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.08.008     Document Type: Article

References (38)

1. Batocchi A.P., Rotondi M., Caggiula M., Frisullo G., Odoardi F., Nociti V., Carella C., Tonali P.A., and Mirabella M. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J. Neuroimmunol. 139 (2003) 150-154
2. Baumann H., Morella K.K., White D.W., Dembski M., Bailon P.S., Kim H., Lai C.F., and Tartaglia L.A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8374-8378
3. Busso N., So A., Chobaz-Peclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., and Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 168 (2002) 875-882
4. Cassatella M.A., Gasperini S., Bovolenta C., Calzetti F., Vollebregt M., Scapini P., Marchi M., Suzuki R., Suzuki A., and Yoshimura A. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94 (1999) 2880-2889
5. Chatzantoni K., Papathanassopoulos P., Gourzoulidou E., and Mouzaki A. Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) in vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients. J. Autoimmun. 23 (2004) 169-177
6. Faggioni R., Jones-Carson J., A., Reed D., Dinarello C.A., Feingold K.R., Grunfeld C., and Fantuzzi G. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2367-2372
7. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68 (2000) 437-446
8. Fateli M., Zarkesh-Esfahani H., Wu Z., Maamra M., Bidlingmaier M., Pockley A.G., Watson P., Matarese G., Strasburger C.J., and Ross R.J. Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J. Immunol. Methods 312 1-2 (2006) 190-200
9. Frisullo G., Angelucci F., Mirabella M., Caggiula M., Patanella K., Nociti V., Tonali P.A., and Batocchi A.P. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients. J. Clin. Immunol. 24 (2004) 287-293
10. Frisullo G., Angelucci F., Caggiula M., Nociti V., Iorio R., Patanella A.K., Sancricca C., Mirabella M., Tonali P.A., and Batocchi A.P. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84 (2006) 1027-1036
11. Ge H., Huang L., Pourbahrami T., and Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J. Biol. Chem. 277 (2002) 45898-45903
12. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
13. Howard J.K., Cave B.J., Oksanen L.J., Tzameli I., Bjorbaek C., and Flier J.S. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10 (2004) 734-738
14. Huang L., Wang Z., and Li C. Modulation of circulating leptin levels by its soluble receptor. J. Biol. Chem. 276 (2001) 6343-6349
15. Kubo M., Hanada T., and Yoshimura A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 (2003) 1169-1176
16. Liu C., Liu X.J., Barry G., Ling N., Maki R.A., and De Souza E.B. Expression and characterization of a putative high affinity human soluble leptin receptor. Endocrinology 138 (1997) 3548-3554
17. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
18. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., and Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (1998) 897-901
19. Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur. Cytokine Netw. 1 (2000) 7-14
20. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., Aufiero D., Fontana S., and Zappacosta S. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5150-5155
21. Matarese G., Di Giacomo A., Sanna V., Lord G.M., Howard J.K., Di Tuoro A., Bloom S.R., Lechler R.I., Zappacosta S., and Fontana S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166 (2001) 5909-5916
22. Mykoniatis A., Anton P.M., Wlk M., Wang C.C., Ungsunan L., Bluher S., Venihaki M., Simeonidis S., Zacks J., Zhao D., Sougioultzis S., Karalis K., Mantzoros C., and Pothoulakis C. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 124 (2003) 683-691
23. Niemand C., Nimmesgern A., Haan S., Fischer P., Schaper F., Rossaint R., Heinrich P.C., and Muller-Newen G. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J. Immunol. 170 (2003) 3263-3272
24. Papathanassoglou E., El-Haschimi K., Li X.C., Matarese G., Strom T., and Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J. Immunol. 176 (2006) 7745-7752
25. Rogge L., Bianchi E., Biffi M., Bono E., Chang S.Y., Alexander H., and Santini C. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25 (2000) 96-101
26. Rottapel R. Putting the brakes on arthritis: can suppressors of cytokine signaling (SOCS) suppress rheumatoid arthritis?. J. Clin. Invest. 108 (2001) 1745-1747
27. Sanchez-Margalet V., Martin-Romero C., Gonzalez-Yanes C., Goberna R., Rodriguez-Bano J., and Muniain M.A. Leptin receptor (Ob-R) expression is induced in peripheral blood mononuclear cells by in vitro activation and in vivo in HIV-infected patients. Clin. Exp. Immunol. 1 (2002) 11-19
28. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., and Matarese G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111 (2003) 241-250
29. Santos-Alvarez J.R., Goberna V., and Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell. Immunol. 194 (1999) 6-11
30. Shuai K., and Liu B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev., Immunol. 3 (2003) 900-911
31. Siegmund B., Lehr H.A., and Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122 (2002) 2011-2025
32. Siegmund B., Sennello J.A., Jones-Carson J., Gamboni-Robertson F., Lehr H.A., Batra A., Fedke I., Zeitz M., and Fantuzzi G. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53 (2004) 965-972
33. Stark J.L., and Cross A.H. Differential expression of suppressors of cytokine signaling-1 and-3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis. Int. Immunol. 18 2 (2006) 347-353
34. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., and Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature 387 (1997) 917-921
35. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., and Dong C. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282 (2007) 9358-9363
36. Yu C.R., Mahdi R.M., Ebong S., Vistica B.P., Chen J., Guo Y., Gery I., and Egwuagu C.E. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173 (2004) 737-746
37. Zarkesh-Esfahani H., Pockley G., Metcalfe R.A., Bidlingmaier M., Wu Z., Ajami A., Weetman A.P., Strasburger C.J., and Ross R.J. High-dose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 167 (2001) 4593-4599
38. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432